Sign in
Enrolling by invitationNo phase

Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study

Key facts

Who runs it
VA Office of Research and Development
Where
Augusta, Decatur, Houston, Little Rock, and Minneapolis, United StatesSee the 5 sites
Trial code
Status
Enrolling by invitation
People taking part
200 people, planned
Started
30 Jul 2024
Expected to end
31 Jul 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Building Spiritual Strength
  • Present Centered Group Therapy
Record updated
20 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Veteran status and:
  • (a) validation of any of the first three items on the Moral Injury and Distress Scale, which is consistent with probable MIS
  • (b) willingness to be randomized to either treatment condition
  • (c) stability on mental health medications for at least 8 weeks
  • (d) age of 18 years or older

Who cannot take part

  • (b) active psychosis or substance use at levels that would interfere with treatment, assessed via chart review, the Alcohol Use Disorders Identification Test - Concise (AUDIT-C) score, and the Mini International Neuropsychiatric Interview (MINI)
  • (a) insufficient capacity to consent
  • (c) currently involved in evidence-based psychotherapy for MIS, or evidence-based psychotherapy for PTSD, assessed via chart review and intake interview
  • (d) managing any severe psychopathology that, in the opinion of the investigative team, requires immediate clinical attention, such as imminent suicide risk, assessed via the MINI and supplemental homicide risk questions

Where in United States

  • Maine VA Medical Center, Augusta, MEAugusta, United StatesEnrolling by invitation
  • Atlanta VA Medical and Rehab Center, Decatur, GADecatur, United StatesEnrolling by invitation
  • Michael E. DeBakey VA Medical Center, Houston, TXHouston, United StatesEnrolling by invitation
  • Central Arkansas Veterans Healthcare System, Little Rock, ARLittle Rock, United StatesEnrolling by invitation
  • Minneapolis VA Health Care System, Minneapolis, MNMinneapolis, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Moral Injury Syndrome (MIS) affects up to 35-60% of Veterans managing combat-related PTSD; it results from experiences that challenge deeply held values or spiritual beliefs. Symptoms of MIS may include hopelessness, helplessness, loss of spiritual beliefs, difficulty with forgiveness, loss of meaning or purpose, reduced trust in self or others, or intractable guilt, shame or anger.

Read full original descriptionShow less

Veterans managing MIS have difficulty responding to mental health treatment, and are at increased risk for suicide ideation or attempts. To date evidence-based interventions for MIS are not widely available in VA. This study will implement an evidence-based intervention for MIS in four VA facilities, collect data on the effectiveness of the intervention, and develop an implementation toolkit. This data will inform national dissemination in collaboration with the Office of Mental Health and Suicide Prevention and the National Chaplain Service.

The 2 groups in the trial

  • Building Spiritual StrengthTreatment being tested

    Spiritually integrated group intervention for moral injury.

  • Present Centered Group TherapyExisting treatment, for comparison

    Coping strategies group intervention addressing broad spectrum trauma symptoms

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
20 July 2026